Smiths Group plc (LON:SMIN) had its target price raised by stock analysts at BNP Paribas from GBX 1,500 ($18.75) to GBX 1,550 ($19.37) in a note issued to investors on Friday. The brokerage presently has a “neutral” rating on the stock. BNP Paribas’ target price suggests a potential upside of 1.51% from the stock’s previous close.

A number of other research firms have also recently weighed in on SMIN. Deutsche Bank AG reaffirmed a “buy” rating and set a GBX 1,587 ($19.83) price target on shares of Smiths Group plc in a report on Friday, January 27th. J P Morgan Chase & Co reaffirmed an “overweight” rating and set a GBX 1,612 ($20.14) price target on shares of Smiths Group plc in a report on Friday, January 27th. Goldman Sachs Group, Inc. (The) reaffirmed a “buy” rating and set a GBX 1,670 ($20.87) price target on shares of Smiths Group plc in a report on Thursday, January 12th. Numis Securities Ltd raised Smiths Group plc to a “buy” rating and set a GBX 1,810 ($22.62) price target on the stock in a report on Tuesday, February 7th. Finally, Morgan Stanley lifted their price target on Smiths Group plc from GBX 890 ($11.12) to GBX 1,300 ($16.25) and gave the company an “underweight” rating in a report on Thursday, October 27th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and eight have given a buy rating to the company. Smiths Group plc currently has a consensus rating of “Hold” and a consensus target price of GBX 1,432.07 ($17.90).

Analyst Recommendations for Smiths Group plc (LON:SMIN)

Smiths Group plc (LON:SMIN) traded down 0.46% during midday trading on Friday, reaching GBX 1527.00. The company had a trading volume of 957,173 shares. The company’s 50 day moving average is GBX 1,490.97 and its 200-day moving average is GBX 1,421.56. Smiths Group plc has a 52-week low of GBX 944.50 and a 52-week high of GBX 1,551.00. The company’s market capitalization is GBX 6.04 billion.

“BNP Paribas Increases Smiths Group plc (SMIN) Price Target to GBX 1,550” was first published by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another website, it was copied illegally and reposted in violation of U.S. and international copyright & trademark laws. The legal version of this article can be accessed at

About Smiths Group plc

Smiths Group plc is a technology company. The Company operates in five divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect and Flex-Tek. The John Crane division offers mechanical seals, seal support systems, engineered bearings and power transmission couplings, among others. The Smiths Medical division offers infusion systems, vascular access (including safety needles), patient airway and temperature management equipment, and specialty devices in areas of in vitro fertilization, diagnostics and emergency patient transport.

Receive News & Ratings for Smiths Group plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smiths Group plc and related companies with Analyst Ratings Network's FREE daily email newsletter.